These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Flow cytometric measurement of NBT-reducing activity in peripheral leukocytes applying THMS H.1TM].
    Author: Nagano S, Umemoto M, Kobayashi K, Matsuoka A.
    Journal: Rinsho Byori; 1990 Jul; 38(7):794-8. PubMed ID: 2169546.
    Abstract:
    Nitroblue tetrazolium (NBT) is reduced to a blue dye (blue formazan, gamma max 560 nm) by superoxide (O2-.) released from phagocytes upon phorbol myristate acetate-stimulation, resulting in the blue dye-deposition on the cell membrane. Thus, we tried to develop a semi-quantification method for determining the NBT-reducing activity in the peripheral leukocytes (NBT-staining intensity -SI- and its distribution in the cell) by flow cytometry. The SI (mean +/- SD) was 28.4 +/- 2.2 (n = 30) in normal subjects and 0.9 in a patient with chronic granulomatous disease, whereas it was 37.6 in a patient with malaria. In addition, patients with myelodysplastic syndrome showed values of 29.2 +/- 7.0 (n = 11), while a patient with partial monosomy of chromosome No. 7 had an SI of 10.8. The present assay of NBT-reducing activity in phagocytes may be useful for screening of peripheral leukocyte function.
    [Abstract] [Full Text] [Related] [New Search]